Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
TMEM216 function has not been fully characterized.
Retinitis pigmentosa 98 is associated with mutations in the TMEM216 gene on chromosome 11.
Genetic testing for TMEM216 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 98 has been reported in the published literature.
No clinical trials have been registered for retinitis pigmentosa 98.
28 publications have been identified in PubMed for retinitis pigmentosa 98. Research spans Basic Science / Preclinical (25%), Epidemiology / Natural History (18%), and Case Report / Case Series (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 7 | 25% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:15 AM UTC
Online Mendelian Inheritance in Man
5 |
18% |
Patient case studies | 4 | 14% |
Testing and diagnosis research | 3 | 11% |
Clinical study results | 3 | 11% |
New treatment approaches | 3 | 11% |
Research summaries | 2 | 7% |
Other research | 1 | 4% |
Daich Varela M (2026). [PMID: 41660487](https://pubmed.ncbi.nlm.nih.gov/41660487/). *Ophthalmol Sci*. [Gene Therapy / Novel Therapeutics]
Hasegawa T (2025). [PMID: 40596570](https://pubmed.ncbi.nlm.nih.gov/40596570/). *Sci Rep*. [Clinical Trial Publication]
Bubis E (2025). [PMID: 40528096](https://pubmed.ncbi.nlm.nih.gov/40528096/). *Graefes Arch Clin Exp Ophthalmol*. [Basic Science / Preclinical]
Wei Q (2025). [PMID: 40051895](https://pubmed.ncbi.nlm.nih.gov/40051895/). *Int J Gen Med*. [Diagnostic / Biomarker]
Jung SH (2025). [PMID: 40560841](https://pubmed.ncbi.nlm.nih.gov/40560841/). *PLoS One*. [Diagnostic / Biomarker]
Parmeggiani F (2025). [PMID: 39774292](https://pubmed.ncbi.nlm.nih.gov/39774292/). *Eye (Lond)*. [Epidemiology / Natural History]
Mäkitie O (2025). [PMID: 38976971](https://pubmed.ncbi.nlm.nih.gov/38976971/). *Horm Res Paediatr*. [Case Report / Case Series]
Daich Varela M (2025). [PMID: 39615819](https://pubmed.ncbi.nlm.nih.gov/39615819/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Ndife TI (2025). [PMID: 40745881](https://pubmed.ncbi.nlm.nih.gov/40745881/). *Niger Postgrad Med J*. [Gene Therapy / Novel Therapeutics]
Zafar A (2025). [PMID: 40141357](https://pubmed.ncbi.nlm.nih.gov/40141357/). *Int J Mol Sci*. [Diagnostic / Biomarker]